Global HPV Testing Market 2014-2018


◆タイトル:Global HPV Testing Market 2014-2018
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆資料形式:pdf / 英語
Single UserUSD2,000 ⇒換算¥218,000見積依頼/購入/質問フォーム
Five UserUSD2,300 ⇒換算¥250,700見積依頼/購入/質問フォーム
Global License(社内共有可)USD10,000 ⇒換算¥1,090,000見積依頼/購入/質問フォーム
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。



TechNavio’s analysts forecast the Global HPV Testing market to grow at a CAGR of 19.43 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in risk of the number of people prone to HPV. The Global HPV Testing market has also been witnessing the increase in mergers & acquisitions. However, the limited number of health clinics could pose a challenge to the growth of this market.
TechNavio’s report, the Global HPV Testing Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global HPV Testing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this space are bioMerieux SA., Hologic Inc., Roche Diagnostics Ltd., and Qiagen N.V.
Other vendors mentioned in the report are Abbott Molecular Inc., Arbor Vita Corp., Becton, Dickinson and Co., IncellDx Inc., Quest Diagnostics Inc., Trovagene Inc., and Ventana Medical Systems Inc.
Key questions answered in this report:
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.


01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Geographical Segmentation
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Trends and their Impact
15. Vendor Landscape
15.1 Competitive Scenario
15.1.1 Key News
15.1.2 Mergers and Acquisitions
15.2 Other Prominent Vendors
16. Key Vendor Analysis
16.1 Qiagen N.V.
16.1.1 Business Overview
16.1.2 Key Information
16.1.3 SWOT Analysis
16.2 Hologic Inc.
16.2.1 Business Overview
16.2.2 Business Segmentation
16.2.3 Key Information
16.2.4 SWOT Analysis
16.3 Roche Diagnostics Ltd
16.3.1 Business Overview
16.3.2 Business Segmentation
16.3.3 Key Information
16.3.4 SWOT Analysis
16.4 bioMerieux SA.
16.4.1 Business Overview
16.4.2 Key Information
16.4.3 SWOT Analysis
17. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global HPV Testing Market 2013-2018 (US$ million)
Exhibit 3: Global HPV Testing Market by Geography 2013 (percent)
Exhibit 4: Business Segmentation of Hologic Inc.
Exhibit 5: Business Segmentation of Roche Diagnostics Ltd.


bioMerieux SA., Hologic Inc., Roche Diagnostics Ltd., and Qiagen N.V.,Abbott Molecular Inc., Arbor Vita Corp., Becton, Dickinson and Co., IncellDx Inc., Quest Diagnostics Inc., Trovagene Inc., and Ventana Medical Systems Inc.



★調査レポート[世界のヒトパピローマウイルス(HPV)検査市場動向(2014-2018)] (Global HPV Testing Market 2014-2018 / IRTNTR3233)販売に関する免責事項
[世界のヒトパピローマウイルス(HPV)検査市場動向(2014-2018)] (Global HPV Testing Market 2014-2018 / IRTNTR3233)についてEメールでお問い合わせ